Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Development unchained: how cellular reprogramming is redefining our view of cell fate and identity.

Efe JA, Yuan X, Jiang K, Ding S.

Sci Prog. 2011;94(Pt 3):298-322. Review.

PMID:
22026150
2.

Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming.

Jung DW, Kim WH, Williams DR.

ACS Chem Biol. 2014 Jan 17;9(1):80-95. doi: 10.1021/cb400754f. Review.

PMID:
24245936
3.

Chemical approaches to cell reprogramming.

Yu C, Liu K, Tang S, Ding S.

Curr Opin Genet Dev. 2014 Oct;28:50-6. doi: 10.1016/j.gde.2014.09.006. Review.

4.

Progress in the reprogramming of somatic cells.

Ma T, Xie M, Laurent T, Ding S.

Circ Res. 2013 Feb 1;112(3):562-74. doi: 10.1161/CIRCRESAHA.111.249235. Review.

5.

The evolving biology of small molecules: controlling cell fate and identity.

Efe JA, Ding S.

Philos Trans R Soc Lond B Biol Sci. 2011 Aug 12;366(1575):2208-21. doi: 10.1098/rstb.2011.0006. Review.

6.

Discovering small molecules to control stem cell fate.

Andrews PD.

Future Med Chem. 2011 Sep;3(12):1539-49. doi: 10.4155/fmc.11.98. Review.

PMID:
21882946
7.

Historical origins of transdifferentiation and reprogramming.

Graf T.

Cell Stem Cell. 2011 Dec 2;9(6):504-16. doi: 10.1016/j.stem.2011.11.012.

8.
9.

Strategies to generate induced pluripotent stem cells.

Hayes M, Zavazava N.

Methods Mol Biol. 2013;1029:77-92. doi: 10.1007/978-1-62703-478-4_6. Review.

PMID:
23756943
10.

Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.

Sanges D, Lluis F, Cosma MP.

Adv Exp Med Biol. 2011;713:137-59. doi: 10.1007/978-94-007-0763-4_9. Review.

PMID:
21432018
11.

Mitochondrial function in pluripotent stem cells and cellular reprogramming.

Bukowiecki R, Adjaye J, Prigione A.

Gerontology. 2014;60(2):174-82. doi: 10.1159/000355050. Review.

12.

Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Ye J, Ge J, Zhang X, Cheng L, Zhang Z, He S, Wang Y, Lin H, Yang W, Liu J, Zhao Y, Deng H.

Cell Res. 2016 Jan;26(1):34-45. doi: 10.1038/cr.2015.142.

13.

Application of epigenome-modifying small molecules in induced pluripotent stem cells.

Lu J, Kong X, Luo C, Li KK.

Med Res Rev. 2013 Jul;33(4):790-822. doi: 10.1002/med.21265. Review.

PMID:
22581616
14.

Advances in reprogramming somatic cells to induced pluripotent stem cells.

Patel M, Yang S.

Stem Cell Rev. 2010 Sep;6(3):367-80. doi: 10.1007/s12015-010-9123-8. Review.

15.

Can controlled cellular reprogramming be achieved using microRNAs?

Sun X, Fu X, Han W, Zhao Y, Liu H.

Ageing Res Rev. 2010 Oct;9(4):475-83. doi: 10.1016/j.arr.2010.06.002. Review.

PMID:
20601195
16.

Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.

Masip M, Veiga A, Izpisúa Belmonte JC, Simón C.

Mol Hum Reprod. 2010 Nov;16(11):856-68. doi: 10.1093/molehr/gaq059. Review.

PMID:
20616150
17.

Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity.

Sayed N, Wong WT, Ospino F, Meng S, Lee J, Jha A, Dexheimer P, Aronow BJ, Cooke JP.

Circulation. 2015 Jan 20;131(3):300-9. doi: 10.1161/CIRCULATIONAHA.113.007394.

18.

A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.

Li Y, Geng YJ.

Growth Horm IGF Res. 2010 Dec;20(6):391-8. doi: 10.1016/j.ghir.2010.09.005. Review.

PMID:
20956084
19.

Recipes and mechanisms of cellular reprogramming: a case study on budding yeast Saccharomyces cerevisiae.

Ding S, Wang W.

BMC Syst Biol. 2011 Apr 12;5:50. doi: 10.1186/1752-0509-5-50.

20.

Roles of small molecules in somatic cell reprogramming.

Su JB, Pei DQ, Qin BM.

Acta Pharmacol Sin. 2013 Jun;34(6):719-24. doi: 10.1038/aps.2013.73. Review.

Items per page

Supplemental Content

Support Center